CClinicalTrials.gg
Sign In
CompletedNCT02027051Updated Aug 30, 2021

Etude génétique Des Arméniens

An observational study in Healthy, sponsored by Institut National de la Santé Et de la Recherche Médicale, France. Completed at 1 site in France. Open to participants aged 50 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-08-30.

Sponsored by Institut National de la Santé Et de la Recherche Médicale, France · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
500
Ages
50 Years and older
Sex
All
01

Study summary

This study aims at better understanding the genetic structure of the Armenians, an old population whose genetics has not been the subject of many studies. We will study 500 individuals whom grandparents originate from different regions of Armenia. Each individual will be genotyped using a large panel of genetic markers. Principal component analysis will be used to analyze the genetic structure of this population.

02

Conditions studied

  • Healthy

Keywords

  • population genetics
03

In context

Lead sponsor

Institut National de la Santé Et de la Recherche Médicale, France is the lead sponsor of 375 studies on the registry; 82 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Descends of individuals originating from Armenia.

Inclusion criteria

  • Four grand-parents originating from Armenia

Exclusion criteria

Exclusion Criteria:

  • One or more grand-parents not originating from Armenia
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
500 participants (actual)
Patient registry
No
Biospecimen retention
Samples with dna
06

What researchers measure

Primary outcomes

  1. Genome wide genotyping of individuals

    Time frame: 3 months following inclusion

Secondary outcomes

  1. Principal component analysis of genotypes

    Time frame: Three months after completion of individual genotypes

Other outcomes

  1. Genetic structure

    Time frame: One month after principal component analysis of individuals

07

Study locations

1 site
  • Hovnanian
    Paris, 75743, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 30, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02027051
Lead sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Responsible party
Sponsor
First posted
Jan 3, 2014
Start date
Jan 2014
Primary completion
Jun 2014
Completion
Jan 2017
Last update
Aug 30, 2021

Study contacts

Emmanuelle Genin, Researcher
study director · Institut National de la Santé Et de la Recherche Médicale, France

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Institut National de la Santé Et de la Recherche Médicale, France

Start the discussion